Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Cansino Biologics Inc
(OP:
CASBF
)
2.570
UNCHANGED
Streaming Delayed Price
Updated: 2:23 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
2.570
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
2.570
Today's Range
2.570 - 2.570
52wk Range
1.860 - 3.550
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
CanSinoBIO Reports Outstanding H1 2024 Performance
August 29, 2024
Via
ACN Newswire
Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership
August 12, 2023
BeiGene and Bristol-Myers Squibb have formally completed the breakup of the BeiGene-Celgene partnership, returning 23.3 million ordinary BeiGene shares to BeiGene. Meanwhile, Gracell Biotechnologies...
Via
Talk Markets
Performance
YTD
-3.93%
-3.93%
1 Month
+2.19%
+2.19%
3 Month
+11.74%
+11.74%
6 Month
+38.17%
+38.17%
1 Year
-11.99%
-11.99%
More News
Read More
Why Is CanSino Biologics (CASBF) Stock Soaring Today?
November 02, 2022
Via
InvestorPlace
Week In Review: Fosun Acquires VerImmune Cancer Immunotherapy In $125 Million Deal
May 28, 2022
Via
Talk Markets
Week In Review: Shanghai Regor To Discover Metabolic Therapies For Lilly In $1.55 Billion Deal
December 11, 2021
Via
Talk Markets
Week In Review: Zai Lab Raises $750 Million In Private Placement For In-Licensed/Novel Drugs
April 24, 2021
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.